Cargando…
Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304749/ http://dx.doi.org/10.1186/1532-429X-14-S1-P212 |
_version_ | 1782226932593590272 |
---|---|
author | Parrington, Diane J Saremi, Aramesh Girotra, Sudhakar V Dev, Sandesh Oh, Charles Scott, Cynthia L Migrino, Raymond Q |
author_facet | Parrington, Diane J Saremi, Aramesh Girotra, Sudhakar V Dev, Sandesh Oh, Charles Scott, Cynthia L Migrino, Raymond Q |
author_sort | Parrington, Diane J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3304749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33047492012-03-16 Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy Parrington, Diane J Saremi, Aramesh Girotra, Sudhakar V Dev, Sandesh Oh, Charles Scott, Cynthia L Migrino, Raymond Q J Cardiovasc Magn Reson Poster Presentation BioMed Central 2012-02-01 /pmc/articles/PMC3304749/ http://dx.doi.org/10.1186/1532-429X-14-S1-P212 Text en Copyright ©2012 Parrington et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Parrington, Diane J Saremi, Aramesh Girotra, Sudhakar V Dev, Sandesh Oh, Charles Scott, Cynthia L Migrino, Raymond Q Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title | Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title_full | Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title_fullStr | Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title_full_unstemmed | Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title_short | Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy |
title_sort | quantification of lvef≤35% misclassification by 2d-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for aicd therapy |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304749/ http://dx.doi.org/10.1186/1532-429X-14-S1-P212 |
work_keys_str_mv | AT parringtondianej quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT saremiaramesh quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT girotrasudhakarv quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT devsandesh quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT ohcharles quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT scottcynthial quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy AT migrinoraymondq quantificationoflvef35misclassificationby2dechocardiographyascomparedtocardiacmagneticresonanceincoronaryarterydiseaseimplicationsforaicdtherapy |